Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$533M |
| 2 |
Apple
AAPL
|
+$347M |
| 3 |
Micron Technology
MU
|
+$272M |
| 4 |
Eli Lilly
LLY
|
+$232M |
| 5 |
Super Micro Computer
SMCI
|
+$185M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$472M |
| 2 |
NVIDIA
NVDA
|
+$413M |
| 3 |
Tesla
TSLA
|
+$403M |
| 4 |
Coinbase
COIN
|
+$236M |
| 5 |
Johnson & Johnson
JNJ
|
+$224M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.66% |
| 2 | Healthcare | 16.81% |
| 3 | Consumer Discretionary | 13.04% |
| 4 | Industrials | 9.63% |
| 5 | Financials | 9.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2601
iShares Russell Top 200 Value ETF
IWX
$4.05B
| $748K | ﹤0.01% |
9,200
+700
| +8% | +$54.6K |
|
2602
Network-1 Technologies
NTIP
$37M
| $747K | ﹤0.01% |
533,868
-30,776
| -5% | -$48.3K |
|
2603
MaxCyte
MXCT
$119M
| $739K | ﹤0.01% |
190,100
-20,814
| -10% | -$87.7K |
|
2604
Stereotaxis
STXS
$135M
| $739K | ﹤0.01% |
362,200
-126,500
| -26% | -$255K |
|
2605
Good Times Restaurants
GTIM
$15M
| $737K | ﹤0.01% |
271,083
+2,800
| +1% | +$7.68K |
|
2606
ECB Bancorp
ECBK
$180M
| $736K | ﹤0.01% |
51,400
+15,000
| +41% | +$202K |
|
2607
Southern California Bancorp
BCAL
$686M
| $736K | ﹤0.01% |
+49,743
| New | +$724K |
|
2608
Oak Valley Bancorp
OVLY
$280M
| $735K | ﹤0.01% |
27,673
-6,843
| -20% | -$178K |
|
2609
Tenaya Therapeutics
TNYA
$157M
| $734K | ﹤0.01% |
380,468
+223,008
| +142% | +$630K |
|
2610
Edgewise Therapeutics
EWTX
$4.78B
| $733K | ﹤0.01% |
+27,465
| New | +$546K |
|
2611
Schwab International Small-Cap Equity ETF
SCHC
$5.59B
| $732K | ﹤0.01% |
19,000
+2,600
| +16% | +$95.7K |
|
2612
Upland Software
UPLD
$12.6M
| $727K | ﹤0.01% |
29,212
+371
| +1% | +$8.55K |
|
|
NIU
2613
Niu Technologies
NIU
$192M
| $725K | ﹤0.01% |
315,200
+10,200
| +3% | +$19.7K |
|
2614
Harte-Hanks
HHS
$16.9M
| $724K | ﹤0.01% |
97,378
+9,478
| +11% | +$74.3K |
|
2615
BARK
BARK
$82.7M
| $724K | ﹤0.01% |
22,201
-14,295
| -39% | -$465K |
|
2616
Precision BioSciences
DTIL
$191M
| $722K | ﹤0.01% |
80,598
-2,400
| -3% | -$23.1K |
|
|
GHLD
2617
DELISTED
Guild Holdings
GHLD
| $722K | ﹤0.01% |
43,400
+15,700
| +57% | +$243K |
|
2618
Q32 Bio
QTTB
$482M
| $721K | ﹤0.01% |
16,164
+1,400
| +9% | +$51.4K |
|
2619
Fulgent Genetics
FLGT
$510M
| $717K | ﹤0.01% |
33,000
-10,900
| -25% | -$244K |
|
2620
iShares Global Healthcare ETF
IXJ
$4.14B
| $717K | ﹤0.01% |
7,300
+1,000
| +16% | +$97K |
|
|
MPX
2621
DELISTED
Marine Products Corp
MPX
| $714K | ﹤0.01% |
73,702
+5,100
| +7% | +$49.1K |
|
2622
Agilon Health
AGL
$1.45B
| $714K | ﹤0.01% |
+7,264
| New | +$938K |
|
2623
Codere Online
CDRO
$405M
| $712K | ﹤0.01% |
89,121
+9,320
| +12% | +$73.9K |
|
2624
a.k.a. Brands
AKA
$118M
| $710K | ﹤0.01% |
30,069
-300
| -1% | -$6.04K |
|
|
HITI
2625
High Tide
HITI
$201M
| $710K | ﹤0.01% |
346,300
+59,200
| +21% | +$117K |
|
Similar funds
Renaissance Technologies's Q3 2024 Portfolio in Review
As of Q3 2024, Renaissance Technologies held 4,024 positions worth $66.5B, up 13% from $59B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Renaissance Technologies deployed $3.2B of net new capital in Q3 2024, opening 578 new positions and adding to 1,558 existing holdings. Its largest new stake was Micron Technology: 2,604,914 shares worth $270M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was NVIDIA, an estimated $413M trimmed.
- Renaissance Technologies's largest Q3 2024 buy was Micron Technology: 2,604,914 shares worth $270M.
- Renaissance Technologies added most to Microsoft in Q3 2024, an estimated $533M increase.
- Renaissance Technologies's biggest Q3 2024 reduction was NVIDIA, cutting an estimated $413M.
- Renaissance Technologies fully exited Broadcom in Q3 2024, selling an estimated $472M.
- Renaissance Technologies's ten largest holdings make up 11% of its $66.5B portfolio in Q3 2024.
- Renaissance Technologies opened 578 new positions and closed 539 in Q3 2024.
- Renaissance Technologies's portfolio value rose 13% quarter-over-quarter to $66.5B.
Based on Renaissance Technologies's 13F filing for Q3 2024, filed 13 Nov 2024.